Brain Fluorine-18 Fluorodeoxyglucose Imaging with Dual-Head Coincidence Gamma Camera:Comparison with Dedicated Ring-Detector PositronEmission Tomography

References

1. ↵
   Coubes P, Awad IA, Antar M, Magdinec M, Sufka B. Comparison and spatial correlation of interictal HMPAO-SPECT and FDG-PET in intractable temporal lobe epilepsy. Neurol Res 1993;15:160-168

   PubMed
2. ↵
   Buchpiguel CA, Alavi JB, Alavi A, Kenyon LC. PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain. J Nucl Med 1995;36:159-164

   Abstract/FREE Full Text
3. ↵
   Weinstein HC, Scheltens P, Hijdra A, van Royen EA. Neuro-imaging in the diagnosis of Alzheimer's disease, II: positron and single photon emission tomography. Clin Neurol Neurosurg 1993;95:81-91

   PubMed
4. ↵
   Conti PS, Keppler JS, Halls JM. Positron emission tomography: a financial and operational analysis. AJR Am J Roentgenol 1994;162:1279-1286

   CrossRefPubMedWeb of Science
5. ↵
   Jarritt PH, Acton PD. PET imaging using gamma camera systems: a review. Nucl Med Commun 1996;17:758-766

   PubMed
6. ↵
   Shreve P, Steventon R, Deters E, Kison P, Gross M, Wahl R. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner. Radiology 1998;207:431-437

   CrossRefPubMedWeb of Science
7. Stokkel MP, Terhaard CH, Mertens IL, Hordijk G, van Rijk PP. Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging. J Nucl Med 1998;39:1385-1387

   Abstract/FREE Full Text
8. ↵
   Delbele D, Patton JA, Martin WH, Sandler MP. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders. J Nucl Med 1999;40:110-117

   Abstract/FREE Full Text
9. ↵
   Wienhard K, Eriksson L, Grootoonk S, Casey M, Pietrzyk U, Heiss WD. Performance evaluation of the positron scanner ECAT EXACT. J Comput Assist Tomogr 1992;16:804-813

   PubMedWeb of Science
10. ↵
    Chang L. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;NS-25:638-643

    CrossRefWeb of Science
11. ↵
    Mayberg HS, Lewis PJ, Regenold W, Wagner HN. Paralimbic hypoperfusion in unipolar depression. J Nucl Med 1994;35:929-934

    Abstract/FREE Full Text
12. ↵
    Matsui T, Hirano A. An Atlas of the Human Brain for Computerized Tomography.. Tokyo: Igaku-Shoin; 1978
13. ↵
    Kume N, Hayashida K, Cho IH, Shimotsu Y, Nishioeda Y, Matsunaga N. Visualization of frontal postural hypoperfusion in patients with Takayasu arteritis with upright 99mTc-HMPAO brain SPECT. Nucl Med Commun 1997;18:943-950

    PubMed
14. Colemann RE, Hoffman JM, Hanson MW, Sostman HD, Schold SC. Clinical application of PET for the evaluation of brain tumors. J Nucl Med 1991;32:616-622

    Abstract/FREE Full Text
15. Fisher RS, Frost JJ. Epilepsy. J Nucl Med 1991;32:651-659

    Abstract/FREE Full Text
16. Minoshima S, Foster NL, Kuhl DE. Posterior cingulate cortex in Alzheimer's disease. Lancet 1994;344:895

    PubMedWeb of Science
17. ↵
    Martin WH, Delbeke D, Patton JA, et al. FDG-SPECT: correlation with FDG-PET. J Nucl Med 1995;36:988-995

    Abstract/FREE Full Text
18. Chen EQ, MacIntyre WJ, Go RT, et al. Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET. J Nucl Med 1997;38:582-586

    Abstract/FREE Full Text
19. ↵
    Drane WE, Nicole MW, Mastin ST, Kuperus JH. SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG). Radiology 1995;197:341-342

    PubMed
20. ↵
    Cherry SR, Dahlbom M, Hoffman EJ. 3D PET using a conventional multislice tomograph without septa. J Comput Assist Tomogr 1991;15:655-66

    CrossRefPubMedWeb of Science
21. ↵
    Srinivasan G, Bacharach SL, Kitsiou AN, Nour KA, Davis CM, Dilsizian V. Delayed FDG imaging improves myocardial/blood pool contrast (abstr). J Am Coll Cardiol 1997;29:436A

    CrossRef
22. Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med 1994;35:1308-1312

    Abstract/FREE Full Text
23. ↵
    Lucignani G, Schmidt KC, Moresco RM, et al. Measurement of regional cerebral glucose utilization with fluorine-18-FDG and PET in heterogeneous tissues: theoretical considerations and practical procedure. J Nucl Med 1993;34:360-369

    Abstract/FREE Full Text